QUOTED. 21 June 2021. Jeff Shuren.
US FDA device center director Jeff Shuren is asking whether the agency’s engagement with industry has been changed forever because of COVID-19.
“I’ve had some companies tell me they never want to go back to the [pre]-COVID situation. And for us, that’s something for us to talk about.” – Jeff Shuren, Director, CDRH, US FDA
- Find out more: ‘A New Kind Of Future’? FDA’s Shuren Questions Whether Engagement With Industry Will Change Post-Pandemic
Click here for a free trial of Medtech Insight